Detalles de la búsqueda
1.
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
JAMA
; 325(16): 1620-1630, 2021 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734299
2.
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Thromb Haemost
; 123(7): 723-733, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944357
3.
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Thromb Haemost
; 122(1): 131-141, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865239
4.
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
Thromb Res
; 198: 135-138, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338976
5.
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Thromb Res
; 196: 382-394, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992075
Resultados
1 -
5
de 5
1
Próxima >
>>